Announcements Trials
Browse Landscape

Phase

Phase 1 2Phase 3 1

Status

Completed 3

Sponsor Class

INDUSTRY 3

Study Type

Interventional 3

Sponsor

Cancer Type

Tumor-Agnostic 2Thoracic 1

Conditions

Carcinoma, Non-Small-Cell Lung 13Neoplasm Metastasis 10Carcinoma, Medullary 10Thyroid Neoplasms 5Lung Neoplasms 5Prostatic Neoplasms 3Neoplasms 3Adenocarcinoma 3Familial medullary thyroid carcinoma 2Colorectal Neoplasms 2Carcinoma, Squamous Cell 2Breast Neoplasms 2Recurrence 1Rectal Neoplasms 1Pleural Effusion 1Pancreatic Neoplasms 1Ovarian Neoplasms 1Multiple Myeloma 1Mesothelioma 1Head and Neck Neoplasms 1Gallbladder Neoplasms 1Differentiated Thyroid Cancer 1Colonic Neoplasms 1Cholangiocarcinoma 1Carcinoma, Large Cell 1Carcinoma, Hepatocellular 1Carcinoma 1Biliary Tract Neoplasms 1Aggression 1Advanced Breast Cancer 1

Interventions

Gemcitabine 22Fluorouracil 14Oxaliplatin 13Capecitabine 13Paclitaxel 12pembrolizumab 11Cisplatin 11Carboplatin 11Pemetrexed 10Leucovorin 9130-nm albumin-bound paclitaxel 9Ramucirumab 8zolbetuximab 7Albumin-Bound Paclitaxel 7trastuzumab deruxtecan 6Drug Therapy 5Docetaxel 5Bevacizumab 5Nivolumab 4Irinotecan 4vandetanib 3cemiplimab 3Everolimus 3EC145 3tislelizumab 2technetium 99m etarfolatide 2spartalizumab 2pralsetinib 2osimertinib 2nimotuzumab 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
INDUSTRY × Adenocarcinoma × vandetanib × Clear all
NCT00404924 2016-09-30

ZD6474 (ZACTIMAâ„¢) Phase III Study in EGFR Failures

Sanofi

Phase 3 Completed
1,140 enrolled 12 charts
Thoracic

Adenocarcinoma, Carcinoma, Non-Small-Cell Lung, Carcinoma, Squamous Cell, Carcinoma, Large Cell

NCT00499850 2016-08-25

Phase I FOLFOX Combination

Sanofi

Phase 1 Completed
18 enrolled
Tumor-Agnostic

Adenocarcinoma

NCT00507091 2016-08-25

Phase I Irinotecan, 5-Fluorouracil and Leucovorin Combination

Sanofi

Phase 1 Completed
24 enrolled
Tumor-Agnostic

Adenocarcinoma, Neoplasm Metastasis

Data powered by HemOnc (CC BY 4.0) Colophon âš¡